Clinical Trial

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To observe the effect of stem cell infusion on the development of acute graft-versus-host disease (aGVHD) in patients with malignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-28; most recent amendment 2025-12-25.
Status change: Recruiting → Active, Not Recruiting 2025-12-25
Status change: Not Yet Recruiting → Recruiting 2024-12-16
Trial Details
NCT Number NCT06294678
Lead Sponsor Anhui Provincial Hospital
Conditions Acute Graft-versus-host Disease
Enrollment 198 participants
Start Date 2024-03-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-31